/ EN
2026-07-15 00:00 Score 80 临床进展

Neuralink PRIME study interim safety report

入组8 例阶段早期可行性
Summary The report discloses electrode channel attrition among early participants; most channels remained stable while a minority showed gradual signal degradation.
Why it matters 通道衰减率是判断该产品长期可靠性的关键指标,也是外界质疑最集中的技术点。
Sources · 3

Neuralink timeline

2026-07 Neuralink expands PRIME trial enrollment to eight participants All entries →
Read original · Original ↗
Suggest a correction Revisions · none / EN
© 2026 BCIwiki About Revisions Submit a tip API